Prothrombin fragment 1+2 measures treatment effect in patients with antiphospholipid syndrome

Thrombosis Research

Volumn 91, Issue 3, 1998, Pages 121-128

  Yamazaki, Masahide ^a,b   Asakura, Hidesaku ^a   Saito, Masanori ^a   Jokaji, Hiroshi ^a   Uotani, Chika ^a   Kumabashiri, Ichiro ^a   Morishita, Eriko ^a   Aoshima, Keiji ^a   Matsuda, Tamotsu ^a   Triplett, Douglas A ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b BALL MEMORIAL HOSPITAL   (United States)

Author keywords

Antiphospholipid syndrome; Prothrombin fragment 1+2; Thrombosis; Treatment; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; PROTHROMBIN; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD CLOTTING; CHILD; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; BIOLOGICAL MARKERS; HUMANS; PEPTIDE FRAGMENTS; PLATELET AGGREGATION INHIBITORS; PROTEIN PRECURSORS; PROTHROMBIN; THROMBOSIS; WARFARIN;

EID: 0032144565     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(98)00074-7     Document Type: Article

References (30)

1. Triplett DA. Protean clinical presentation of antiphospholipid-protein antibodies (APA). Thromb Haemost 1995;74:329-37.
2. Feinstein DI. Lupus anticoagulant, thrombosis and fetal loss. N Engl J Med 1985;313:1348-50.
3. Harris EN, Asherson RA, Gharavi AE, Morgan SH, Derue GD, Hughes GRV. Thrombocytopenia in SLE and related autoimmune disorders: Association with anticardiolipin antibody. Br J Haematol 1985;59:227-30.
4. Yamazaki M. Lupus anticoagulant. Rinshoui 1992;117:983-7. (In Japanese).
5. Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Aoshima K, Ikeda T, Matsuda T. Plasma levels of lipoprotein(a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost 1994;71:424-7.
6. Rosove MH, Brewer PMC. Antiphospholipid thrombosis clinical course after the first thrombotic events in 70 patients. Ann Intern Med 1992;117:303-8.
7. Silveria LH, Hubble CL, Jara LJ, Saway S, Martinez-Osuma P, Seleznick MJ, Angel J, O'Brien W, Espinoza LR. Prevention of anticardiolipin antibody-related pregnancy losses with prednisolone and aspirin. Am J Med 1992;93:403-11.
8. Piette JC. Prevention of recurrent thrombosis in the antiphospholipid syndrome. Lupus 1994; 3:73-4.
9. Pelzer H, Stuber W. Markers of hemostatic activation: New perspective using immunochemical methods for determination of prothrombin fragment 1+2 and thrombin- antithrombin III complex. Thromb Haemost 1989;62:165.
10. Asakura H, Shiratori Y, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T. Changes in plasma levels of prothrombin fragment F1+2 in cases of disseminated intravascular coagulation. Acta Haematol 1993;89:22-5.
11. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324-6.
12. Asherson RA. A "primary" antiphospholipid syndrome? J Rheumatol 1988;15:1742-6.
13. Derkson RHWM, DeGroot PG, Kater L, Neiwenhuis HK. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 1993;52:689-92.
14. Exner T, Rickard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioral patterns. Br J Haematol 1978; 40:143-51.
15. Triplett DA, Brandt JT, Kaczor D, Schaeffer J. Laboratory diagnosis of lupus inhibitors: A comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure. Am J Clin Pathol 1983; 79:678-82.
16. Rosove MN, Ismail M, Koziol BJ, Runge A, Kasper CK. Lupus anticoagulants: With a kaolin clotting time using rabbit brain phospholipid in standard and high concentrations. Blood 1986;68:472-8.
17. Wagenknecht DR, McIntyre JA. Changes in β2 glycoprotein I antigenicity induced by phospholipid binding. Thromb Haemost 1993; 70: 598-602.
18. Engvall E, Perlman P. Enzyme-linked immunosorbent assay (ELISA). Immunochemistry 1971;8:871-4.
19. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with enzyme-linked immunosorbent assay. Thromb Haemost 1988;59: 101-6.
20. Sakata Y, Murakami T, Noro A, Mori K, Matsuda M. The specific activity of plasminogen activator inhibitor-1 in disseminated intravascular coagulation with acute promyelocytic leukemia. Blood 1991;77:1949-57.
21. Asakura H, Jokaiji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol 1991;38:281-7.
22. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM. Association of levels of lipoprotein(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 1986;74: 2540-4.
23. Asakura H, Hifumi H, Jokaji H, Saito M, Kumabashiri I, Uotani C, Morishita E, Yamazaki M, Shibata K, Mizuhashi K, Mifune J, Matsuda T. Prothrombin fragment F1+2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagulat Fibrinol 1992;3:469-73.
24. Vaarala O, Alfthan G, Jauhiainen M, Leirisalo Repo M, Aho K, Palosuo T. Crossreaction between antibodies to oxidised low-density lipoprotein and cardiolipin in systemic lupus erythematosus. Lancet 1993;341:923-5.
25. Amengual O, Atsumi T, Khamashta MA, Tinahones F, Hughes GR. Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. Br J Rhematol 1997;36:964-8.
26. Cowchock S. Prevention of fetal death in the antiphospholipid antibody syndrome. Lupus 1996;5:467-72.
27. Rai R, Cohen H, Dave M, Regan L. Randomized controlled trial of aspirin and aspirin plus heparin in pregnant woman with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). Br Med J 1997;314:253-7.
28. Rosendaal FR. Risk factors for venous thrombosis: Prevalance, risk, and interaction. Sem Hematol 1997;34:171-87.
29. Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants. Ann Intern Med 1997;127:177-85.
30. Rapaport SI, Le DT. Thrombosis in the antiphopspholipid antibody syndrome. N Engl J Med 1995;333:665.